How to rapidly identify Refractory psychosis and what to do about it

Presented By: 

Kara Dempster, MD, MSC, FRCPC

Assistant Professor, Department of Psychiatry, Dalhousie University

Associate Clinical Director, Nova Scotia Early Psychosis Program

Halifax, NS

Learning Objectives: 

• Discuss treatment response in early psychosis.

• Define an expected time course of response.

• Define treatment resistant schizophrenia (TRS).

• Discuss the limitations of traditional criteria for TRS in early psychosis populations

• Establish a management approach for early psychosis patients with residual symptoms.

• Review the evidence for clozapine for TRS

Originally Presented at 2023 Expert Speaker Series​​​

This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance, and Teva through an educational grant.